Denali Therapeutics Inc
NASDAQ: DNLI
$24.22
Closing Price on November 21, 2024
DNLI Stock Chart and Intraday Price
DNLI Stock Data
Asset Type | Stock |
Exchange | NASDAQ |
Currency | USD |
Country | USA |
Sector | LIFE SCIENCES |
Industry | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
Address | 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, US |
Fiscal Year End | December |
Latest Quarter | 12/31/2023 |
Market Cap | 2,882.79M USD |
Shares Outstanding | 138,197,000 |
DNLI Articles
Wednesday's additional analyst upgrades and downgrades included CrowdStrike, Ecolab, KKR, Microsoft, Tilray Brands and Twilio.
Published:
Monday's top analyst upgrades and downgrades included Broadcom, Costco Wholesale, DraftKings, Exxon Mobil, Foot Locker, Marvell Technology, Nvidia, Payoneer Global, Philip Morris International, Pure...
Published:
Tuesday's top analyst upgrades and downgrades included AT&T, Comcast, First Solar, Fortinet, Jefferies Financial, Next Era Energy Partners, T-Mobile and Walt Disney.
Published:
Wednesday’s top analyst upgrades and downgrades included Apple, AMC Entertainment, Facebook, First Solar, Kansas City Southern, Roku and SolarEdge.
Published:
Last Updated:
Monday's top analyst upgrades and downgrades included Albermarle, Apple, Consolidated Edison, Etsy, GoHealth, Hecla Mining, NortonLifeLock, Pinterest, Switch and T-Mobile.
Published: